Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹113.88Admitted-Finance CORPORATE HOUSE B D SAWANT MARG CHAKALA ANDHERI EAST MUMBAI MUMBAI MAHARASHTRA 400099 | MUMBAI SUBURBAN | MAHARASHTRA | 400099 | L1 | Admitted-Finance | |
| 2 | L2₹158.13+₹44.25 (38.9%)Admitted-Finance G 5 B I D C GORWA VADODARA GUJARAT INDIA 390016 | VADODARA | VADODARA | GUJARAT | 390016 | L2 | Admitted-Finance | |
| 3 | L3₹760.67+₹646.79 (568.0%)Admitted-Finance MSN HOUSE PLOT NO C 24 INDUSTRIAL ESTATE SANATHNAGAR HYDERABAD TELANGANA INDIA 500018 | HYDERABAD | HYDERABAD | TELANGANA | 500018 | L3 | Admitted-Finance | |
| 4 | L4₹795.80+₹681.92 (598.8%)Admitted-Finance SURVEY NO 80 84 MELANGE TOWERS 4TH FLOOR C WING PATRIKA NAGAR MADHAPUR HYDERABAD TELANGANA 500081 | HYDERABAD | HYDERABAD | TELANGANA | 500081 | L4 | Admitted-Finance | |
| 5 | L5₹846.41+₹732.53 (643.2%)Admitted-Finance | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | KHANDELWAL LABORATORIES PVT. LTD. L13 | BDR Pharmaceuticals International Pvt. Ltd. L12 | Intas Pharmaceuticals Ltd L23 | VENUS REMEDIES LIMITED L11 | Reliance Life Sciences Pvt. Ltd. L22 | Hetero Healthcare Limited L4 | Glenmark Pharmaceuticals Ltd. L1 | Centurion Remedies Pvt. Ltd. L2 | Fresenius Kabi Oncology Limited L10 | MSN Laboratories Private Limited L3 | ALBINO LIFESCIENCES PVT. LTD. L9 | Sparsha Pharma International Private Limited L7 | Dr Reddys Laboratories Limited L14 | Enzene Biosciences Limited L20 | NATCO PHARMA LIMITED L5 | M/s Beta Drugs Limited L17 | United Biotech Pvt. Ltd. L18 | ADMAC LIFESCIENCES L15 | Medicamen Biotech Limited L6 | Naprod Life Sciences Pvt Ltd L19 | BRUCK PHARMA PVT LTD L16 | Zydus Lifesciences Limited L21 | RUSAN PHARMA LTD. L8 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Tab. Eltrombopag Olamine (Aluminium foil/Blister pack), 25 mg/Tab | 1 | Per Tab. | - | - | - | - | - | 38.14 ₹38.14 | - | - | - | - | - | - | - | - | 55.71 ₹55.71 | - | - | - | 23.4 ₹23.4 Lowest | - | - | - | - |
| 2.00 | Tab. Cyclophosphamide (Aluminium foil/Blister pack), 50 mg/Tab | 1 | Per Tab. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.00 | Inj. Cyclophosphamide, 200mg/Vial | 1 | Per Inj. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 4.00 | Inj. Cyclophosphamide (with diluents), 500mg/vial | 1 | Per Inj. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5.00 | Inj. Cyclophosphamide, 1gm/Vial | 1 | Per Inj. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 6.00 | Tab. Methotrexate (coated) (Aluminium foil/Blister pack), 2.5 mg/Tab | 1 | Per Tab. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 7.00 | Inj. Doxorubicin HCl, 2 mg / ml | 1 | Per Inj. | 66 ₹66 | - | - | - | - | - | - | - | 139 ₹139 | - | - | - | - | - | - | - | 78 ₹78 | - | - | - | 55 ₹55 Lowest | - | - |
| 8.00 | Inj. Vincristine Sulphate, 1mg / ml | 1 | Per Inj. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 48 ₹48 Lowest | - | - | - | - | - | - |
| 9.00 | Inj. Cisplatin, 10 mg/Vial | 1 | Per Inj. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 108 ₹108 | - | - | - | 98 ₹98 Lowest | - | - | - |
| 10.00 | Inj. Cisplatin, 50 mg / vial | 1 | Per Inj. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 388 ₹388 Lowest | - | - | - | 449 ₹449 | - | - | - |
Tender Value
Refer Docs
Closing Date
20 Jul 2026, 6:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MD OSMCL
Odisha State Medical Corporation Ltd.,In front of Ram Mandir, Convent Square, Unit III, Bhubaneswar
supply of Anti Cancer Items (Group-II)
2026_OSMCL_130081_1
OSMCL/2026-27/ DRUGS-DHS-ACD-GR-II/02
National Competitive Bid
Medicines
Item Rate
OSMCL BHUBANESWAR
Please refer Tender documents.
3 documents required · 3 mandatory
₹5,900
Odisha State Medical Corporation Ltd.
Exempted
1 Oct 2026
1 Jun 2026
27 Jul 2026
1 Jun 2026
20 Jul 2026
8 Jun 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Tab. Eltrombopag Olamine (Aluminium foil/Blister pack), 25 mg/Tab | - | Per Tab. | - | - |
| 2 | Tab. Cyclophosphamide (Aluminium foil/Blister pack), 50 mg/Tab | - | Per Tab. | - | - |
| 3 | Inj. Cyclophosphamide, 200mg/Vial | - | Per Inj. | - | - |
| 4 | Inj. Cyclophosphamide (with diluents), 500mg/vial | - | Per Inj. | - | - |
| 5 | Inj. Cyclophosphamide, 1gm/Vial | - | Per Inj. | - | - |
| 6 | Tab. Methotrexate (coated) (Aluminium foil/Blister pack), 2.5 mg/Tab | - | Per Tab. | - | - |
| 7 | Inj. Doxorubicin HCl, 2 mg / ml | - | Per Inj. | - | - |
| 8 | Inj. Vincristine Sulphate, 1mg / ml | - | Per Inj. | - | - |
| 9 | Inj. Cisplatin, 10 mg/Vial | - | Per Inj. | - | - |
| 10 | Inj. Cisplatin, 50 mg / vial | - | Per Inj. | - | - |
stage.html
html • 0.08 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.60 MB
BOQ_593146.xls
BOQ • 0.48 MB
DOC.pdf
Tender Documents • 2.28 MB
DATECORRIGENDUM.pdf
PDF • 0.08 MB
PREBID.pdf
PDF • 0.16 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .